Sustained-release oral molsidomine composition for treating atherosclerosis

Details for Australian Patent Application No. 2005239799 (hide)

Owner Therabel Pharmaceuticals Limited

Inventors Geczy, Jozsef-Michel

Agent Spruson & Ferguson

Pub. Number AU-B-2005239799

PCT Pub. Number WO2005/107761

Priority 04/03534 05.04.04 FR

Filing date 1 April 2005

Wipo publication date 17 November 2005

Acceptance publication date 23 December 2010

International Classifications

A61K 31/5377 (2006.01)

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/107761 Priority application(s): WO2005/107761

23 December 2010 Application Accepted

  Published as AU-B-2005239799

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005239801-Water-soluble films for releasing active substances

2005239796-Method and device for enhancing the treatment of teeth and gums